Meglitinides (e.g. repaglinide, nateglinide)  
* increase pancreatic insulin secretion
* like sulfonylureas they bind to an ATP\-dependent K\+(KATP) channel on the cell membrane of pancreatic beta cells
* often used for patients with an erratic lifestyle
* adverse effects include weight gain and hypoglycaemia (less so than sulfonylureas)
